+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis



Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis



Arthritis and Rheumatism 64(10): 3150-3155



To assess the sensitivity and specificity of the Classification of Psoriatic Arthritis (CASPAR) Study Group criteria in early psoriatic arthritis (PsA) and to compare them with the sensitivity and specificity of the Moll and Wright criteria. The CASPAR Study Group criteria were applied to patients with early PsA (<24 months symptom duration) and to control patients with other new-onset inflammatory arthritides. Both groups were naive to all disease-modifying antirheumatic drugs. The gold standard diagnosis was confirmed by the consulting rheumatologist using radiography and magnetic resonance imaging where required. Proportions of patients and control patients meeting the criteria were compared using McNemar's tests. We recruited a total of 111 patients with early PsA and 111 control patients with other forms of inflammatory arthritis (82 with rheumatoid arthritis, 13 with undifferentiated arthritis, 9 with spondylarthritis, 4 with inflammatory osteoarthritis, and 3 with crystal arthritis) to the study. The sensitivity of the CASPAR Study Group criteria in classifying early PsA was 87.4% compared to 80.2% for the Moll and Wright criteria. The specificity for both criteria was 99.1%. When considering different cut points for the CASPAR Study Group criteria, the best cut point for classification remained a score of ≥ 3 as in the original CASPAR Study Group analysis. Considering a score of ≥ 2 gave a higher sensitivity of 99.1% but resulted in a drop in specificity to 94.6%. Regression analysis determined that psoriasis and rheumatoid factor negativity were the most important features that differentiated PsA, followed by nail psoriasis and current or previous dactylitis. The CASPAR Study Group criteria are more sensitive than the Moll and Wright criteria in classifying early PsA. Although their sensitivity for early PsA is lower than that for established disease, the CASPAR Study Group criteria are valid for use as inclusion criteria for trials in early PsA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055712370

Download citation: RISBibTeXText

PMID: 22576997

DOI: 10.1002/art.34536


Related references

Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis and Rheumatism 57(8): 1560-1563, 2007

Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Journal of Rheumatology 36(2): 368-370, 2009

Summary of Sensitivity and Specificity for Psoriatic Arthritis in a South African Cohort according to Classification Criteria. Journal of Rheumatology 42(6): 960-962, 2016

The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study. Journal of Rheumatology 39(1): 154-156, 2012

The performance of psoriatic arthritis classification criteria in Turkish patients with psoriatic arthritis. International Journal of Rheumatic Diseases 20(8): 985-989, 2017

Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis cohort. Annals of the Rheumatic Diseases 71(8): 1366-1369, 2012

Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. Journal of Rheumatology 35(10): 2069-70; Author Reply 2070, 2008

DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort. Clinical and Experimental Rheumatology 35(6): 936-942, 2017

Screening psoriatic arthritis tools: analysis of the Early Arthritis for Psoriatic Patients questionnaire. Rheumatology 54(1): 200-202, 2015

The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. Bmc Musculoskeletal Disorders 14: 101, 2013

Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Annals of the Rheumatic Diseases 73(2): 407-413, 2014

Clinical experience in 115 patients with arthritis and/or enthesitis who met the classification criteria for psoriatic arthritis (CASPAR) within the last two years-Possible association with malignant disorders. Modern Rheumatology 26(4): 625-629, 2016

THU0637Impact of Psoriatic Arthritis: Linking The Domains of Health Which Are Important for Patients with Psoriatic Arthritis To The International Classification of Functioning, Disability and Health. Annals of the Rheumatic Diseases 75(Suppl 2): 425.1-425, 2016

Rapidly progressive destructive arthritis in psoriatic arthritis sine psoriasis: do bone resorption marker levels predict outcome of bone destruction in psoriatic arthritis?. Modern Rheumatology 21(1): 106-108, 2011

SAT0403Further Analysis of Psoriatic Arthritis Disease Activity Score (PASDAS) and Composite Psoriatic Disease Activity Index (CPDAI) Using Data from A Placebo-Controlled TRIAL of Certolizumab Pegol in Psoriatic Arthritis. Annals of the Rheumatic Diseases 73(Suppl 2): 740.1-740, 2014